ESPACE (874710)

  https://cordis.europa.eu/project/id/874710

  Horizon 2020 (2014-2020)

  Human Cell Atlas of the Pancreas

  Pilot actions to build the foundations of a human cell atlas (SC1-BHC-31-2019)

  proteomics  ·  diabetes  ·  oncology  ·  enzymes  ·  epigenetics

  2020-01-01 Start Date (YY-MM-DD)

  2022-06-30 End Date (YY-MM-DD)

  € 4,962,494 Total Cost


  Description

The human pancreas is a physiologically unique organ involved in the secretion of several hormones, such as insulin, thus regulating blood sugar levels, as well as the secretion of enzymes for the digestive system. Several human diseases are associated with the pancreas: Pancreatic andenocarcinoma is one of the most aggressive cancers in humans and pancreatitis is a common potentially life-threatening disorder related to adverse lifestyle conditions. A very common chronical disease affecting the pancreas is Diabetes mellitus, a metabolic disorder that is characterised by high blood sugar levels due to the lack of insulin produced in the pancreas. Despite its high physiological importance, the high autolytic activity makes the pancreas a challenging tissue to study. The Expression and Spatial analysis Pancreas Atlas Consortium Europe, ESPACE, has formed as merger of three prior Human Cell Atlas (HCA) early pilot studies of the pancreas funded by the Chan Zuckerberg initiative. Based on the there developed methods and standards for sample procurement, single cell profiling, spatial proteomics, and computational pipelines we will here build a first version of the Human Cell Atlas of the Pancreas. We will integrate molecular profiles, including transcriptome and epigenomics data from more than 1 million single cells jointly together with tissue proteomics allowing to address fundamental questions of cell state and phenotype in healthy adults and during foetal development. Thus, we will provide a first version of an open single cell repository of the pancreas built upon the Data Coordination Platform of the HCA. Exploring the benefit of the HCA of the pancreas for tackling pancreatic diseases, ESPACE will reach out into types 2 diabetes. Besides creating a unique and first of its kind comprehensive atlas of the human pancreas the methods and standards developed by ESPACE will be of high relevance for HCA projects in other organs.


  Complicit Organisations

1 Israeli organisation participates in ESPACE.

Country Organisation (ID) VAT Number Role Activity Type Total Cost EC Contribution Net EC Contribution
Netherlands ACADEMISCH ZIEKENHUIS LEIDEN (999990849) NL003566213B01 participant HES € 358,250 € 358,250 € 358,250
Sweden KUNGLIGA TEKNISKA HOEGSKOLAN (999990946) SE202100305401 participant HES € 556,316 € 556,316 € 556,316
Netherlands KONINKLIJKE NEDERLANDSE AKADEMIE VAN WETENSCHAPPEN - KNAW (999518362) NL002958697B01 participant OTH € 697,000 € 697,000 € 447,000
Germany TECHNISCHE UNIVERSITAET MUENCHEN (999977463) DE811193231 participant HES € 383,568 € 383,568 € 383,568
Germany STEINBEIS TRANSFER GMBH (999759116) DE814628518 participant PRC € 43,750 € 43,750 € 43,750
Netherlands UNIVERSITAIR MEDISCH CENTRUM UTRECHT (999915189) NL004205315B01 thirdParty HES € 250,000 € 0 € 250,000
Israel RESEARCH FUND OF THE HADASSAH MEDICAL ORGANIZATION (R.A) (934508186) IL580166387 participant REC € 190,000 € 190,000 € 190,000
Italy OSPEDALE SAN RAFFAELE SRL (953176030) IT07636600962 participant PRC € 295,750 € 295,750 € 295,750
Germany CHARITE - UNIVERSITAETSMEDIZIN BERLIN (999992692) DE228847810 coordinator HES € 1,089,173 € 1,089,173 € 1,089,173
Spain FUNDACIO CENTRE DE REGULACIO GENOMICA (999544455) ESG62426937 participant REC € 1,162,436 € 1,162,436 € 1,162,436
Germany LINQ MANAGEMENT GMBH (916451054) DE815651752 participant PRC € 186,250 € 186,250 € 186,250